Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A global tumor Paint study in Patients with brain and spinal cord tumors

Trial Profile

A global tumor Paint study in Patients with brain and spinal cord tumors

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tozuleristide (Primary)
  • Indications Brain cancer; Nervous system neoplasms
  • Focus Diagnostic use
  • Most Recent Events

    • 30 Apr 2018 New trial record
    • 24 Apr 2018 According a Gateway for Cancer Research media release, Dr. Leary is working on this trial via the Pacific Pediatric Neuro Oncology Consortium (PNOC) with pediatric brain tumor research institutions in the US and Canada.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top